<p>Prestige Consumer Healthcare（纽约证券交易所代码：PBH - 获取免费报告）于周四发布了季度财报。该公司报告季度每股收益为 1.07 美元，超出分析师一致预期的 0.97 美元，超出幅度为 0.10 美元，Zacks 报道。Prestige Consumer Healthcare 的股本回报率为 12.69%，净利润率为 19.02%。该季度的营业收入为 2.7411 亿美元，而一致预期为 2.5714 亿美元。在去年同期，该公司每股收益为 1.09 美元。该季度的营业收入同比下降了 3.4%。Prestige Consumer Healthcare 更新了其 2026 财年的指引，预计每股收益为 4.540-4.580 美元。</p>
<h2>Prestige Consumer Healthcare 股价下跌 2.5%</h2>
<p>周五交易时段，PBH 股价下跌 1.51 美元，达到 59.85 美元。该股票交易量为 578,048 股，而其平均交易量为 417,609 股。Prestige Consumer Healthcare 的 52 周低点为 59.51 美元，52 周高点为 90.04 美元。该公司的市值为 29.5 亿美元，市盈率为 14.05，PEG 比率为 1.93，贝塔值为 0.41。该公司的债务与股本比率为 0.55，流动比率为 4.38，速动比率为 2.99。该公司的 50 日简单移动平均线为 62.98 美元，200 日简单移动平均线为 73.18 美元。</p>
<h2>Prestige Consumer Healthcare 的机构交易</h2>
<p>大型投资者最近调整了对该公司的持股。美国银行（Bank of America Corp DE）在第二季度将其在 Prestige Consumer Healthcare 的持股增加了 19.1%。美国银行目前拥有 721,371 股该公司的股票，价值 57,601,000 美元，此前在该期间购买了 115,459 股。制造商人寿保险公司（The Manufacturers Life Insurance Company）在第二季度将其在 Prestige Consumer Healthcare 的持股增加了 12.9%。制造商人寿保险公司目前拥有 553,407 股该公司的股票，价值 44,190,000 美元，此前在上个季度购买了 63,168 股。高盛集团（Goldman Sachs Group Inc.）在第一季度将其在 Prestige Consumer Healthcare 的持股增加了 28.4%。高盛集团目前拥有 546,672 股该公司的股票，价值 46,997,000 美元，此前在上个季度购买了 120,965 股。公共部门养老金投资委员会（Public Sector Pension Investment Board）在第二季度将其在 Prestige Consumer Healthcare 的持股增加了 6.2%。公共部门养老金投资委员会目前拥有 189,134 股该公司的股票，价值 15,102,000 美元，此前在该期间购买了 11,115 股。最后，Jane Street Group LLC 在第二季度将其在 Prestige Consumer Healthcare 的持股增加了 25.3%。Jane Street Group LLC 目前拥有 131,337 股该公司的股票，价值 10,487,000 美元，此前在上个季度购买了 26,535 股。目前 99.95% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师的升级和降级</h2>
<p>几位股票研究分析师对 PBH 股票发表了评论。杰富瑞金融集团（Jefferies Financial Group）在 10 月 27 日的研究报告中将 Prestige Consumer Healthcare 的目标价从 75.00 美元下调至 71.00 美元，并对该公司给予 “持有” 评级。华尔街 Zen 在 8 月 9 日的报告中将 Prestige Consumer Healthcare 的评级从 “买入” 下调至 “持有”。奥本海默（Oppenheimer）在 10 月 21 日的研究报告中将 Prestige Consumer Healthcare 的目标价从 82.00 美元下调至 72.00 美元，并对该公司给予 “跑赢大盘” 评级。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Prestige Consumer Healthcare 的 “持有（c）” 评级。最后，加拿大皇家银行（Canaccord Genuity Group）在周五的研究报告中将 Prestige Consumer Healthcare 的目标价从 100.00 美元下调至 88.00 美元，并对该公司给予 “买入” 评级。四位股票研究分析师对该股票给予 “买入” 评级，三位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，共识目标价为 85.33 美元。</p>
<p><strong>查看我们对 Prestige Consumer Healthcare 的最新分析</strong></p>
<h2>关于 Prestige Consumer Healthcare</h2>
<p>（获取免费报告）</p>
<p>Prestige Consumer Healthcare Inc 及其子公司在美国和国际上开发、制造、营销、分销和销售非处方（OTC）健康和个人护理产品。该公司分为两个部门，北美 OTC 医疗保健和国际 OTC 医疗保健。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Prestige Consumer Healthcare</li>
<li>REIT 股票 - 今天值得加入您投资组合的最佳 REIT 股票</li>
<li>Rivian 的图表显示可以买入，但一些分析师仍然持否定态度</li>
<li>想在下跌趋势中获利？下跌趋势解析。</li>
<li>e.l.f.的抛售是购买的好时机，分析师表示</li>
<li>医疗保健股票解析：为什么您可能想要投资</li>
<li>T-Mobile 是最被低估的巨型股票——现在是买入时机吗？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBCSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBCSA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1,000 美元在 Prestige Consumer Healthcare 吗？</h2>
<p>在您考虑 Prestige Consumer Healthcare 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Prestige Consumer Healthcare 并不在名单上。</p>
<p>虽然普雷斯蒂奇消费医疗目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

普雷斯蒂奇

<p>Prestige Consumer Healthcare（纽约证券交易所代码：PBH）报告的季度每股收益为 1.07 美元，超出预期 0.10 美元。收入为 2.7411 亿美元，超过预期的 2.5714 亿美元，但同比下降 3.4%。公司更新了 2026 财年的指引，预计每股收益在 4.540-4.580 美元之间。尽管盈利表现积极，PBH 的股价仍下跌 2.5%，至 59.85 美元。机构投资者持有 99.95% 的股份，主要公司近期对持股进行了调整。分析师的评级意见不一，普遍评级为 “持有”，目标价为 85.33 美元</p>

<p>Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) released its quarterly earnings data on Thursday. The company reported $1.07 EPS for the quarter, topping analysts' consensus estimates of $0.97 by $0.10, Zacks reports. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The business had revenue of $274.11 million during the quarter, compared to the consensus estimate of $257.14 million. During the same period in the prior year, the firm posted $1.09 EPS. The business's revenue for the quarter was down 3.4% on a year-over-year basis. Prestige Consumer Healthcare updated its FY 2026 guidance to 4.540-4.580 EPS.</p>
<div class="lb-trans"><p>Prestige Consumer Healthcare（纽约证券交易所代码：PBH - 获取免费报告）于周四发布了季度财报。该公司报告季度每股收益为 1.07 美元，超出分析师一致预期的 0.97 美元，超出幅度为 0.10 美元，Zacks 报道。Prestige Consumer Healthcare 的股本回报率为 12.69%，净利润率为 19.02%。该季度的营业收入为 2.7411 亿美元，而一致预期为 2.5714 亿美元。在去年同期，该公司每股收益为 1.09 美元。该季度的营业收入同比下降了 3.4%。Prestige Consumer Healthcare 更新了其 2026 财年的指引，预计每股收益为 4.540-4.580 美元。</p>
</div><h2>Prestige Consumer Healthcare Stock Down 2.5%</h2>
<div class="lb-trans"><h2>Prestige Consumer Healthcare 股价下跌 2.5%</h2>
</div><p>PBH traded down $1.51 during trading hours on Friday, reaching $59.85. 578,048 shares of the stock traded hands, compared to its average volume of 417,609. Prestige Consumer Healthcare has a fifty-two week low of $59.51 and a fifty-two week high of $90.04. The company has a market cap of $2.95 billion, a price-to-earnings ratio of 14.05, a PEG ratio of 1.93 and a beta of 0.41. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99. The firm's fifty day simple moving average is $62.98 and its two-hundred day simple moving average is $73.18.</p>
<div class="lb-trans"><p>周五交易时段，PBH 股价下跌 1.51 美元，达到 59.85 美元。该股票交易量为 578,048 股，而其平均交易量为 417,609 股。Prestige Consumer Healthcare 的 52 周低点为 59.51 美元，52 周高点为 90.04 美元。该公司的市值为 29.5 亿美元，市盈率为 14.05，PEG 比率为 1.93，贝塔值为 0.41。该公司的债务与股本比率为 0.55，流动比率为 4.38，速动比率为 2.99。该公司的 50 日简单移动平均线为 62.98 美元，200 日简单移动平均线为 73.18 美元。</p>
</div><h2>Institutional Trading of Prestige Consumer Healthcare</h2>
<div class="lb-trans"><h2>Prestige Consumer Healthcare 的机构交易</h2>
</div><p>Large investors have recently modified their holdings of the business. Bank of America Corp DE raised its holdings in shares of Prestige Consumer Healthcare by 19.1% during the second quarter. Bank of America Corp DE now owns 721,371 shares of the company's stock worth $57,601,000 after purchasing an additional 115,459 shares during the period. The Manufacturers Life Insurance Company grew its position in shares of Prestige Consumer Healthcare by 12.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 553,407 shares of the company's stock valued at $44,190,000 after buying an additional 63,168 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of Prestige Consumer Healthcare by 28.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 546,672 shares of the company's stock valued at $46,997,000 after buying an additional 120,965 shares during the last quarter. Public Sector Pension Investment Board raised its stake in Prestige Consumer Healthcare by 6.2% during the second quarter. Public Sector Pension Investment Board now owns 189,134 shares of the company's stock worth $15,102,000 after acquiring an additional 11,115 shares during the period. Finally, Jane Street Group LLC lifted its holdings in Prestige Consumer Healthcare by 25.3% in the second quarter. Jane Street Group LLC now owns 131,337 shares of the company's stock worth $10,487,000 after acquiring an additional 26,535 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>大型投资者最近调整了对该公司的持股。美国银行（Bank of America Corp DE）在第二季度将其在 Prestige Consumer Healthcare 的持股增加了 19.1%。美国银行目前拥有 721,371 股该公司的股票，价值 57,601,000 美元，此前在该期间购买了 115,459 股。制造商人寿保险公司（The Manufacturers Life Insurance Company）在第二季度将其在 Prestige Consumer Healthcare 的持股增加了 12.9%。制造商人寿保险公司目前拥有 553,407 股该公司的股票，价值 44,190,000 美元，此前在上个季度购买了 63,168 股。高盛集团（Goldman Sachs Group Inc.）在第一季度将其在 Prestige Consumer Healthcare 的持股增加了 28.4%。高盛集团目前拥有 546,672 股该公司的股票，价值 46,997,000 美元，此前在上个季度购买了 120,965 股。公共部门养老金投资委员会（Public Sector Pension Investment Board）在第二季度将其在 Prestige Consumer Healthcare 的持股增加了 6.2%。公共部门养老金投资委员会目前拥有 189,134 股该公司的股票，价值 15,102,000 美元，此前在该期间购买了 11,115 股。最后，Jane Street Group LLC 在第二季度将其在 Prestige Consumer Healthcare 的持股增加了 25.3%。Jane Street Group LLC 目前拥有 131,337 股该公司的股票，价值 10,487,000 美元，此前在上个季度购买了 26,535 股。目前 99.95% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师的升级和降级</h2>
</div><p>Several equities research analysts have commented on PBH shares. Jefferies Financial Group dropped their price target on Prestige Consumer Healthcare from $75.00 to $71.00 and set a &#34;hold&#34; rating for the company in a research note on Monday, October 27th. Wall Street Zen cut Prestige Consumer Healthcare from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, August 9th. Oppenheimer dropped their target price on shares of Prestige Consumer Healthcare from $82.00 to $72.00 and set an &#34;outperform&#34; rating for the company in a research report on Tuesday, October 21st. Weiss Ratings reaffirmed a &#34;hold (c)&#34; rating on shares of Prestige Consumer Healthcare in a research report on Wednesday, October 8th. Finally, Canaccord Genuity Group decreased their price objective on shares of Prestige Consumer Healthcare from $100.00 to $88.00 and set a &#34;buy&#34; rating for the company in a research note on Friday. Four equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of &#34;Hold&#34; and a consensus price target of $85.33.</p>
<div class="lb-trans"><p>几位股票研究分析师对 PBH 股票发表了评论。杰富瑞金融集团（Jefferies Financial Group）在 10 月 27 日的研究报告中将 Prestige Consumer Healthcare 的目标价从 75.00 美元下调至 71.00 美元，并对该公司给予 “持有” 评级。华尔街 Zen 在 8 月 9 日的报告中将 Prestige Consumer Healthcare 的评级从 “买入” 下调至 “持有”。奥本海默（Oppenheimer）在 10 月 21 日的研究报告中将 Prestige Consumer Healthcare 的目标价从 82.00 美元下调至 72.00 美元，并对该公司给予 “跑赢大盘” 评级。Weiss Ratings 在 10 月 8 日的研究报告中重申了对 Prestige Consumer Healthcare 的 “持有（c）” 评级。最后，加拿大皇家银行（Canaccord Genuity Group）在周五的研究报告中将 Prestige Consumer Healthcare 的目标价从 100.00 美元下调至 88.00 美元，并对该公司给予 “买入” 评级。四位股票研究分析师对该股票给予 “买入” 评级，三位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “持有”，共识目标价为 85.33 美元。</p>
</div><p><strong>View Our Latest Analysis on Prestige Consumer Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Prestige Consumer Healthcare 的最新分析</strong></p>
</div><h2>About Prestige Consumer Healthcare</h2>
<div class="lb-trans"><h2>关于 Prestige Consumer Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.</p>
<div class="lb-trans"><p>Prestige Consumer Healthcare Inc 及其子公司在美国和国际上开发、制造、营销、分销和销售非处方（OTC）健康和个人护理产品。该公司分为两个部门，北美 OTC 医疗保健和国际 OTC 医疗保健。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Prestige Consumer Healthcare</li>
<li>REIT Stocks - Best REIT Stocks to Add to Your Portfolio Today</li>
<li>Rivian’s Chart Says Go, But Some Analysts Still Say No</li>
<li>Want to Profit on the Downtrend? Downtrends, Explained.</li>
<li>e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts</li>
<li>Health Care Stocks Explained: Why You Might Want to Invest</li>
<li>T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Prestige Consumer Healthcare</li>
<li>REIT 股票 - 今天值得加入您投资组合的最佳 REIT 股票</li>
<li>Rivian 的图表显示可以买入，但一些分析师仍然持否定态度</li>
<li>想在下跌趋势中获利？下跌趋势解析。</li>
<li>e.l.f.的抛售是购买的好时机，分析师表示</li>
<li>医疗保健股票解析：为什么您可能想要投资</li>
<li>T-Mobile 是最被低估的巨型股票——现在是买入时机吗？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBCSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=PBH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Prestige Consumer Healthcare Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元在 Prestige Consumer Healthcare 吗？</h2>
</div><p>Before you consider Prestige Consumer Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Prestige Consumer Healthcare 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Prestige Consumer Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Prestige Consumer Healthcare 并不在名单上。</p>
</div><p>While Prestige Consumer Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然普雷斯蒂奇消费医疗目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

普雷斯蒂奇消费保健品公司（NYSE:PBH）公布季度财报，每股收益超出预期 0.10 美元